Healthy Clinical Trial
Official title:
Assessing Novel Methods of Improving Patient Education of Nutrition: eHealth, Health Literacy and Chronic Kidney Disease
1. Research question Can a web-based nutritional educational intervention improve
phosphorus knowledge and control of phosphorus intake?
2. Experimental design
Following enrollment and informed consent, subjects will be randomized to one of two
arms (group1: usual care; group 2: usual care plus Internet-based nutrition module).
All subjects will undergo baseline data collection, consisting of:
1. Short form of the test of functional health literacy in adults: categorizes
individuals as having adequate, marginal or inadequate health literacy.
2. Chronic Kidney Disease (CKD) Knowledge Assessment Tool: addresses nutritional
knowledge of CKD.
3. SF-12 Health Survey version 2: a 12-item measure of health related quality of
life.
4. Kidney Disease Self-Management Survey: a 58-item Likert scale based on theories
important for self-management in chronic disease.
5. 3-Day Dietary Diaries
6. Lab work:
i. Serum phosphorus, calcium and parathyroid hormone levels. ii. Circulating
endothelial cells, a novel marker for vascular damage.
Following baseline data collection, group 1 will continue with their scheduled clinic
visit, while group 2 will spend approximately 30 minutes completing a web-based
nutrition module. After completion of the module, patients will proceed with their
scheduled clinic visit.
All subjects will then be asked to return in 30-60 days to repeat some of the survey
information and blood work
3. Major risks to subjects There is the potential for some mild discomfort from the
necessary blood draws, which occur twice per subjects.
4. Potential benefits to subjects Subjects randomized to the web-based module may receive
an educational benefit from it.
5. Consent procedures Only individuals who can provide their own consent can participate.
Upon agreeing to enroll, a study coordinator or investigator will provide the subject
with a copy of the consent form, and will remain available to answer any questions.
Specific Aim 1: To examine the effect of a novel, web-based method of educating CKD patients
on patient knowledge and dietary intake of phosphorus. We will compare 2 methods for
educating CKD patients about dietary phosphorus intake:
1. Usual care, consisting of individualized care/counseling by a nephrologist.
2. Usual care, plus review of the Kidney School (KS) Nutrition Module (see below). To
compare gains in phosphorus knowledge after 1 month. To compare compliance with dietary
phosphorus intake, as measured by mineral metabolism laboratory values (serum
phosphorus, calcium, PTH, calcium-phosphorus product) and 3-day dietary diaries.
Specific Aim 2: To determine if the S-TOFHLA predicts CKD patients' knowledge and compliance
with recommended dietary phosphorus intake:
1. To measure health literacy in patients undergoing maintenance hemodialysis, using the
S-TOFHLA.
2. To assess correlations between health literacy and knowledge of phosphorus.
3. To assess correlations between health literacy and compliance with CKD dietary
phosphorus guidelines, as measured by mineral metabolism laboratory values (serum
phosphorus, calcium, PTH, calcium-phosphorus product), and dietary phosphate intake, as
measured by 3-day dietary diaries.
4. To assess correlations between health literacy and compliance with CKD dietary
phosphorus guidelines, following usual care versus an eHealth nutrition intervention.
Specific Aim 3: To determine if higher dietary phosphorus intake correlates with higher
levels of CECs.
1. To measure CEC levels in patients with CKD.
2. To assess correlations between dietary phosphorus intake, serum phosphorus levels, and
CECs in patients with CKD.
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |